| 摘要 |
Silver (II) Oxide preferentially reacts with tNOX a cancer-specific ECTO-NOX protein of the surface of cancer cells. The combination of the cancer specificity of tNOX and the interaction of silver II oxide specified herein with tNOX offer new and novel therapeutic and diagnostic opportunities including but not restricted to coupling with one or more commercially available silver enhancement protocols for cancer detection as well as detection of an age-related ECTO-NOX form, designated ar-NOX.
|
